Long-term Persistence of Dysplastic Features in Patients with Acute Promyelocytic Leukemia Treated with All-trans Retinoic Acid and Arsenic Trioxide

被引：0
作者：
Santinelli, Enrico [1 ,2 ]
Pascale, Maria Rosaria [1 ]
Guarnera, Luca [1 ]
Savi, Arianna [3 ]
Mallegni, Flavia [4 ]
Catanoso, Maria Luigia [5 ]
Gurnari, Carmelo [4 ,6 ]
Maurillo, Luca [7 ]
Voso, Maria Teresa [4 ]
Fenu, Susanna [8 ]
机构：
[1] Univ Roma Tor Vergata, Dept Biomed & Prevent, PhD Program Immunol Mol Med & Appl Biotechnol, I-00133 Rome, Italy
[2] Fdn Policlin Univ Campus Biomed, Via Alvaro Portillo,200, I-00128 Rome, Italy
[3] Univ Turin, Dept Clin & Biol Sci, I-10043 Turin, Italy
[4] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy
[5] Bambino Gesu Pediat Hosp, Ist Ricovero & Cura Carattere Sci, Dept Pediat Hematol Oncol Cell & Gene Therapy, Rome, Italy
[6] Cleveland Clin, Taussig Canc Ctr, Translat Hematol & Oncol Res Dept, Cleveland, OH USA
[7] Fdn Policlin Tor Vergata, Hematol, I-00133 Rome, Italy
[8] San Giovanni Addolorata Hosp, Haematol Dept, Rome, Italy
来源：
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES | 2025年 / 17卷 / 01期
关键词：
Dysplasia; Acute promyelocytic leukemia; Arsenic trioxide; BONE-MARROW DYSPLASIA; MYELODYSPLASTIC SYNDROME; MYELOID NEOPLASMS; CLASSIFICATION; CHEMOTHERAPY;
D O I：
10.4084/MJHID.2025.038
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 20 条
[1]   AIDA (all-trans retinoic acid plus idarubicin) in newly diagnosed acute promyelocytic leukemia: A Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Pilot study [J].
Avvisati, G ;
LoCoco, F ;
Diverio, D ;
Falda, M ;
Ferrara, F ;
Lazzarino, M ;
Russo, D ;
Petti, MC ;
Mandelli, F .
BLOOD, 1996, 88 (04) :1390-1398
[2]   Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial [J].
Cicconi, Laura ;
Platzbecker, Uwe ;
Avvisati, Giuseppe ;
Paoloni, Francesca ;
Thiede, Christian ;
Vignetti, Marco ;
Fazi, Paola ;
Ferrara, Felicetto ;
Divona, Mariadomenica ;
Albano, Francesco ;
Efficace, Fabio ;
Sborgia, Marco ;
Di Bona, Eros ;
Breccia, Massimo ;
Borlenghi, Erika ;
Cairoli, Roberto ;
Rambaldi, Alessandro ;
Melillo, Lorella ;
La Nasa, Giorgio ;
Fiedler, Walter ;
Brossart, Peter ;
Hertenstein, Bernd ;
Salih, Helmut R. ;
Annibali, Ombretta ;
Wattad, Mohammed ;
Lubbert, Michael ;
Brandts, Christian H. ;
Hanel, Mathias ;
Rollig, Christoph ;
Schmitz, Norbert ;
Link, Hartmut ;
Frairia, Chiara ;
Fozza, Claudio ;
D'Arco, Alfonso Maria ;
Di Renzo, Nicola ;
Cortelezzi, Agostino ;
Fabbiano, Francesco ;
Dohner, Konstanze ;
Ganser, Arnold ;
Dohner, Hartmut ;
Amadori, Sergio ;
Mandelli, Franco ;
Voso, Maria Teresa ;
Ehninger, Gerhard ;
Schlenk, Richard F. ;
Lo-Coco, Francesco .
LEUKEMIA, 2020, 34 (03) :914-918
[3]   Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes [J].
Della Porta, M. G. ;
Travaglino, E. ;
Boveri, E. ;
Ponzoni, M. ;
Malcovati, L. ;
Papaemmanuil, E. ;
Rigolin, G. M. ;
Pascutto, C. ;
Croci, G. ;
Gianelli, U. ;
Milani, R. ;
Ambaglio, I. ;
Elena, C. ;
Ubezio, M. ;
Da Via, M. C. ;
Bono, E. ;
Pietra, D. ;
Quaglia, F. ;
Bastia, R. ;
Ferretti, V. ;
Cuneo, A. ;
Morra, E. ;
Campbell, P. J. ;
Orazi, A. ;
Invernizzi, R. ;
Cazzola, M. ;
Network, R. E. L. Clinical .
LEUKEMIA, 2015, 29 (01) :66-75
[4]   Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy [J].
Efficace, Fabio ;
Platzbecker, Uwe ;
Breccia, Massimo ;
Cottone, Francesco ;
Carluccio, Paola ;
Salutari, Prassede ;
Di Bona, Eros ;
Borlenghi, Erika ;
Autore, Francesco ;
Levato, Luciano ;
Finizio, Olimpia ;
Mancini, Valentina ;
D'Ardia, Stefano ;
Schlenk, Richard F. ;
Melillo, Lorella ;
Fumagalli, Monica ;
Fiedler, Walter ;
Beltrami, Germana ;
Fracchiolla, Nicola Stefano ;
Bernardi, Massimo ;
Fazi, Paola ;
Annibali, Ombretta ;
Mayer, Karin ;
Voso, Maria Teresa ;
Vignetti, Marco .
BLOOD ADVANCES, 2021, 5 (21) :4370-4379
[5]   Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxide [J].
Eghtedar, Alireza ;
Rodriguez, Ildefonso ;
Kantarjian, Hagop ;
O'Brien, Susan ;
Daver, Naval ;
Garcia-Manero, Guillermo ;
Ferrajoli, Alessandra ;
Kadia, Tapan ;
Pierce, Sherry ;
Cortes, Jorge ;
Ravandi, Farhad .
LEUKEMIA & LYMPHOMA, 2015, 56 (05) :1342-1345
[6]  
FEUSSNER JR, 1979, BLOOD, V53, P820
[7]  
Gaut Daria, 2018, Leuk Res Rep, V9, P65, DOI 10.1016/j.lrr.2018.04.005
[8]   Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem [J].
Latagliata, R ;
Petti, MC ;
Fenu, S ;
Mancini, M ;
Spiriti, MAA ;
Breccia, M ;
Brunetti, GA ;
Avvisati, G ;
Lo Coco, F ;
Mandelli, F .
BLOOD, 2002, 99 (03) :822-824
[9]   Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia [J].
Lo-Coco, F. ;
Avvisati, G. ;
Vignetti, M. ;
Thiede, C. ;
Orlando, S. M. ;
Iacobelli, S. ;
Ferrara, F. ;
Fazi, P. ;
Cicconi, L. ;
Di Bona, E. ;
Specchia, G. ;
Sica, S. ;
Divona, M. ;
Levis, A. ;
Fiedler, W. ;
Cerqui, E. ;
Breccia, M. ;
Fioritoni, G. ;
Salih, H. R. ;
Cazzola, M. ;
Melillo, L. ;
Carella, A. M. ;
Brandts, C. H. ;
Morra, E. ;
von Lilienfeld-Toal, M. ;
Hertenstein, B. ;
Wattad, M. ;
Luebbert, M. ;
Haenel, M. ;
Schmitz, N. ;
Link, H. ;
Kropp, M. G. ;
Rambaldi, A. ;
La Nasa, G. ;
Luppi, M. ;
Ciceri, F. ;
Finizio, O. ;
Venditti, A. ;
Fabbiano, F. ;
Doehner, K. ;
Sauer, M. ;
Ganser, A. ;
Amadori, S. ;
Mandelli, F. ;
Doehner, H. ;
Ehninger, G. ;
Schlenk, R. F. ;
Platzbecker, U. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) :111-121
[10]   Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience [J].
Lobe, I ;
Rigal-Huguet, F ;
Vekhoff, A ;
Desablens, B ;
Bordessoule, D ;
Mounier, C ;
Ferrant, A ;
Sanz, M ;
Fey, M ;
Chomienne, C ;
Chevret, S ;
Degos, L ;
Fenaux, P .
LEUKEMIA, 2003, 17 (08) :1600-1604
12